A Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 134, Issue Supplement_1, Pages 3157-3157

出版商

American Society of Hematology

发表日期

2019-11-14

DOI

10.1182/blood-2019-122902

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now